ORIC PHARMACEUTICALS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-43.6M | $25.8M |
| FY2018 | — | $-64.4M | $42.6M |
| FY2019 | — | $-90.1M | $89.2M |
| FY2020 | — | $289.8M | $78.4M |
| FY2021 | $10.5M | $273.0M | $226.0M |
| FY2022 | — | $222.4M | $66.8M |
| FY2023 | — | $224.1M | $23.4M |
| FY2024 | — | $243.1M | $59.4M |
| FY2025 | — | $384.4M | $45.7M |